Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
Clinical trial NCT03984318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03984318
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2026-12-11
- Enrollment
- 1240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.